Jian Zhang



Jian Zhang 

Director of heart failure center and HFCU of Fuwai Hospital CAMS&PUMC

Standing member of academic committee of National Center for Cardiovascular Disease, Fuwai Hospital

Vice chief standing member of the expert committee of Nation Center for Cardiovascular Disease

Vice president of the ethics committee of National Clinical Research Center for Cardiovascular Diseases

Director of  experts committee of  heart failure quality control group of national cardiovascular diseases quality control expert committee

Chief of National Heart Failure Medical Consortium, CHS

Chief member of  heart failure committee in CMDA

Vice director  of the 11th cardiovascular emergency and critical care group of CHS

Chief editor of Chinese journal of heart failure and cardiomyopathy

Standing editor of Chinese Circulation Journal

Member of editor committee in Chinese Journal of Cardiology, Chinese journal of geriatrics and Chinese Journal of Clinicians.

Chief of  GW-ICC 2018,CIHFC and the heart failure and cardio-oncology forum of CHC and GW-ICC.


Selected Publications

  1. Noncoding RNA CPR (Cardiomyocyte Proliferation Regulator) Regulates Cardiomyocyte Proliferation and Cardiac Repair.
  2. 2018 Chinese Guideline for the diagnosis and treatment of acute and chronic heart failure.
  3. Contemporary Epidemiology, Management, and Outcomes of Patients Hospitalized for Heart Failure in China: Results From the China Heart Failure (China-HF) Registry
  4. E2F1-dependent miR-421 regulates mitochondrial fragmentation and myocardial infarction by targeting Pink1
  5. Prognostic value of sST2 and galectin-3 for death relative to renal function in patients hospitalized for heart failure
  6. The Utility of Galectin-3 for Predicting Cause-Specific Death in Hospitalized Patients With Heart Failure
  7. Frequency and Predictors of Normalization of Left Ventricular

Ejection Fraction in Recent-Onset Nonischemic Cardiomyopathy

  1. A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of the Effects of Qili Qiangxin Capsules in Patients With Chronic Heart Failure
  2. Comparison of Characteristics and Short-Term Outcome From

Fungal Infective Endocarditis in Prosthetic Valve Endocarditis Versus Native Valve Endocarditis

  1. A Phase II, Randomized, double-Blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of the Efficacy and Safety of ecombinant Human Neuregulin-1 in Patients With Chronic Heart Failure
  2. Empagliflozin in Heart Failure with a Preserved Ejection Fraction.